TWI861021B - 染色體生物標記 - Google Patents

染色體生物標記 Download PDF

Info

Publication number
TWI861021B
TWI861021B TW108138132A TW108138132A TWI861021B TW I861021 B TWI861021 B TW I861021B TW 108138132 A TW108138132 A TW 108138132A TW 108138132 A TW108138132 A TW 108138132A TW I861021 B TWI861021 B TW I861021B
Authority
TW
Taiwan
Prior art keywords
obd154
obd142
horse
markers
training
Prior art date
Application number
TW108138132A
Other languages
English (en)
Chinese (zh)
Other versions
TW202035704A (zh
Inventor
伊旺 杭特
阿洛爾 瑞瑪達斯
艾力山卓 阿考里特雀夫
Original Assignee
英商牛津生物力學公眾有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817181.9A external-priority patent/GB201817181D0/en
Priority claimed from GBGB1904066.6A external-priority patent/GB201904066D0/en
Application filed by 英商牛津生物力學公眾有限公司 filed Critical 英商牛津生物力學公眾有限公司
Publication of TW202035704A publication Critical patent/TW202035704A/zh
Application granted granted Critical
Publication of TWI861021B publication Critical patent/TWI861021B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW108138132A 2018-10-22 2019-10-22 染色體生物標記 TWI861021B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1817181.9A GB201817181D0 (en) 2018-10-22 2018-10-22 Chromosome biomarker
GB1817181.9 2018-10-22
GBGB1904066.6A GB201904066D0 (en) 2019-03-25 2019-03-25 Chromosome biomarker
GB1904066.6 2019-03-25

Publications (2)

Publication Number Publication Date
TW202035704A TW202035704A (zh) 2020-10-01
TWI861021B true TWI861021B (zh) 2024-11-11

Family

ID=68296533

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108138132A TWI861021B (zh) 2018-10-22 2019-10-22 染色體生物標記

Country Status (13)

Country Link
US (1) US12584172B2 (https=)
EP (1) EP3870719A1 (https=)
JP (1) JP7599417B2 (https=)
KR (1) KR102901797B1 (https=)
CN (1) CN113366121A (https=)
AU (1) AU2019363806B2 (https=)
CA (1) CA3115024A1 (https=)
IL (1) IL282089B2 (https=)
MY (1) MY204616A (https=)
SG (1) SG11202103603VA (https=)
TW (1) TWI861021B (https=)
WO (1) WO2020084289A1 (https=)
ZA (1) ZA202102664B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220170766A (ko) 2021-06-22 2022-12-30 주식회사 엘지화학 단백질 키나아제 억제제로서의 신규한 화합물
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207661A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection processes using sites of chromosome interaction
CN108359732A (zh) * 2017-01-25 2018-08-03 株式会社大熊制药 用于预测训练反应的生物标志物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998744B2 (en) 2008-07-28 2011-08-16 Greenwood Genetic Center, Inc. Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders
WO2012106559A1 (en) 2011-02-02 2012-08-09 Translational Genomics Research Institute Biomarkers and methods of use thereof
US9284594B2 (en) 2013-07-23 2016-03-15 The Regents Of The University Of Michigan Compositions and methods relating to fusion protein biomarkers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207661A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection processes using sites of chromosome interaction
CN108359732A (zh) * 2017-01-25 2018-08-03 株式会社大熊制药 用于预测训练反应的生物标志物

Also Published As

Publication number Publication date
IL282089A (en) 2021-05-31
WO2020084289A1 (en) 2020-04-30
AU2019363806A1 (en) 2021-05-06
KR102901797B1 (ko) 2025-12-17
IL282089B2 (en) 2024-08-01
SG11202103603VA (en) 2021-05-28
CN113366121A (zh) 2021-09-07
KR20210080516A (ko) 2021-06-30
US20220282328A1 (en) 2022-09-08
ZA202102664B (en) 2022-10-26
CA3115024A1 (en) 2020-04-30
IL282089B1 (en) 2024-04-01
JP2022512842A (ja) 2022-02-07
JP7599417B2 (ja) 2024-12-13
AU2019363806B2 (en) 2022-03-31
EP3870719A1 (en) 2021-09-01
NZ775029A (en) 2025-03-28
MY204616A (en) 2024-09-05
US12584172B2 (en) 2026-03-24
TW202035704A (zh) 2020-10-01

Similar Documents

Publication Publication Date Title
CN109661477B (zh) 与乳腺癌相关的染色体相互作用的检测
Xu et al. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions
KR20240025672A (ko) Rna 번역 상태의 단일-세포 프로파일링
CA3078198A1 (en) Pool type liquid metal fast spectrum reactor using a printed circuit heat exchanger connection to the power conversion system
TWI861021B (zh) 染色體生物標記
US20200407790A1 (en) Biomarker
JP2022113834A (ja) カロリー制限およびカロリー制限模倣物の同定用マーカー
US11535893B2 (en) Typing method
JP2022512842A5 (https=)
TWI884984B (zh) 診斷染色體標記
CA3209544A1 (en) Chromosome interaction markers
Ye et al. Investigation of the relationship between SLA-1 and SLA-3 gene expression and susceptibility to Escherichia coli F18 in post-weaning pigs
WO2025062136A1 (en) Chromosome detection assay
Zhao et al. Screening of molecular signatures from microRNA and mRNA expression profiling related to the efficacy of the antidepressant duloxetine and analysis of their regulatory relationship
TW202548029A (zh) 染色體標記測試
CN117305429A (zh) Tacr3基因在检测神经元神经递质释放中的用途
CN112824539A (zh) 一种通过rs571770来特异性检测少肌症的试剂盒